Analyst Ranking
Bottom 2%
#4882 out of 4937 analysts
Average Return
-3.27%
Win Rate
37%170 out of 461
Risk vs Reward
Poor
Good

Douglas Tsao's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Praxis Precision Medicines IncPRAX
+428.38%$14.55$76.88
2023-11-15 -
2024-11-14
Buy
Praxis Precision Medicines IncPRAX
+319.68%$17.68$74.20
2023-12-05 -
2024-12-04
Buy
Cabaletta Bio IncCABA
+313.27%$1.96$8.10
2022-03-18 -
2023-03-17
Buy
Rezolute IncRZLT
+287.90%$1.24$4.81
2024-02-14 -
2025-02-13
Buy
Praxis Precision Medicines IncPRAX
+267.73%$15.00$55.16
2023-04-14 -
2024-04-12
Buy

Douglas Tsao Analyst Color

Get additional color on Douglas Tsao's coverage of popular stocks

Douglas Tsao's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Disc Medicine IncIRON
16Buy$118.00+107.34%Reiterates
10 days ago
Argenx SeARGX
37Buy$720.00+28.52%Reiterates
12 days ago
Crinetics Pharmaceuticals IncCRNX
22Buy$81.00+153.68%Reiterates
16 days ago
Roivant Sciences LtdROIV
20Buy$18.00+58.45%Reiterates
25 days ago
Sage Therapeutics IncSAGE
21Hold$12.00+29.45%Reiterates
a month ago
Cabaletta Bio IncCABA
25Buy$25.00+1,336.78%Reiterates
a month ago
Protagonist Therapeutics IncPTGX
29Buy$80.00+50.94%Reiterates
a month ago
Xenon Pharmaceuticals IncXENE
5Buy$53.00+64.55%Reiterates
2 months ago
Praxis Precision Medicines IncPRAX
23Buy$105.00+107.76%Reiterates
2 months ago
Coherus Biosciences IncCHRS
25Buy$7.00+695.45%Reiterates
2 months ago
Rezolute IncRZLT
17Buy$14.00+166.16%Reiterates
2 months ago
Viridian Therapeutics IncVRDN
16Buy$34.00+99.53%Reiterates
3 months ago
Evolus IncEOLS
22Buy$27.00+184.81%Reiterates
3 months ago
Arcutis Biotherapeutics IncARQT
4Buy$19.00+26.58%Reiterates
3 months ago
Dare Bioscience IncDARE
17Buy$12.00+377.14%Reiterates
3 months ago
Scpharmaceuticals IncSCPH
14Buy$18.00+310.96%Reiterates
4 months ago
Immunovant IncIMVT
21Buy$51.00+181.30%Reiterates
4 months ago
Neumora Therapeutics IncNMRA
7Buy$18.00+1,295.35%Reiterates
4 months ago
Biohaven LtdBHVN
9Buy$54.00+287.65%Reiterates
4 months ago
Apellis Pharmaceuticals IncAPLS
26Buy$57.00+193.21%Reiterates
4 months ago
Theravance Biopharma IncTBPH
13Buy$15.00+32.74%Reiterates
5 months ago
Minerva Neurosciences IncNERV
14Hold$5.00+197.62%Reiterates
5 months ago
Outlook Therapeutics IncOTLK
15Buy$3.00+44.93%Maintains
5 months ago
Alkermes PLCALKS
15Hold$46.00+51.92%Reiterates
5 months ago
Trevena IncTRVN
9Hold$5.00+100.00%Downgrades
8 months ago
Marinus Pharmaceuticals IncMRNS
18Hold$2.00+263.64%Reiterates
8 months ago
Revance Therapeutics IncRVNC
18Hold$6.60+80.82%Reiterates
8 months ago
EVO
9Buy$8.00-12.18%Reiterates
8 months ago
Aeon Biopharma IncAEON
8Buy$360.00+42,757.14%Reiterates
9 months ago
Cerevel Therapeutics Holdings IncCERE
6Hold$45.00N/ADowngrades
2 years ago
Rvl Pharmaceuticals PLCRVLPQ
3Buy$3.00N/AMaintains
2 years ago
Climb Bio IncCLYM
2Hold$6.00N/AReiterates
2 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Hold$74.00N/AInitiates Coverage On
3 years ago
Therapeuticsmd IncTXMD
5Hold$10.00N/ADowngrades
3 years ago
Biohaven Pharmaceutical Holding Co LtdBHVN1
4HoldN/AN/ADowngrades
3 years ago
Histogen IncHSTOQ
2Buy$30.00N/AMaintains
3 years ago
Amryt Pharma PLCAMYT
2Buy$18.00N/AMaintains
3 years ago
Radius Health IncRDUS1
5Hold$10.00N/AMaintains
4 years ago
Gw Pharmaceuticals PLCGWPH
3Hold$220.00N/ADowngrades
4 years ago
Amag Pharmaceuticals IncAMAG
2Hold$13.75N/ADowngrades
5 years ago
Momenta Pharmaceuticals IncMNTA
4Hold$52.50N/ADowngrades
5 years ago
Chiasma IncCHMA
2Buy$10.00N/AMaintains
5 years ago
Dermira IncDERM2
1Hold$18.75N/ADowngrades
5 years ago
Icon PLCICLR
3Hold$148.00N/AMaintains
6 years ago
Teva Pharmaceutical Industries LtdTEVA
5Hold$23.00N/AMaintains
7 years ago
Pacira Biosciences IncPCRX
1Strong Buy$50.00N/AMaintains
7 years ago
Phibro Animal Health CorpPAHC
1Strong Sell$33.00N/AMaintains
7 years ago
Pfenex IncPFNX
1Strong Buy$8.00N/AMaintains
7 years ago
Endo International PLCENDPQ
1Hold$10.00N/AMaintains
7 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.